.RESEARCH STUDY HIGHLIGHT.06 August 2024.
A big randomized controlled test with cisgender women highlights the difficulties of fidelity to an everyday oral preexposure prevention routine and also displays that twice-yearly shot of lenacapavir can easily preserve helpful HIV prevention levels over 6 months.